| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $395.6M | +14.1% | +7.1% |
| Cost of Revenue | $44.7M | +3.5% | +24.8% |
| Gross Profit | $350.9M | +15.6% | +5.1% |
| R&D Expense | $63.7M | -7.9% | +3.2% |
| SG&A Expense | $76.0M | +8.1% | +7.9% |
| Operating Income | $112.9M | +81.7% | +4.8% |
| Pre-tax Income | $119.7M | +67.2% | -0.5% |
| Income Tax | $24.2M | +35.3% | -13.5% |
| Net Income | $94.9M | +78.0% | +3.4% |
| EPS (Basic) | $1.00 | +78.6% | +5.3% |
| EPS (Diluted) | $0.99 | +80.0% | +5.3% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $594.3M | -7.7% | -5.2% |
| Short-term Investments | $460K | -37.8% | — |
| Accounts Receivable | $391.3M | +4.9% | +24.6% |
| Inventory | $31.9M | +2.1% | -7.7% |
| Current Assets | $1.41B | +0.5% | +1.8% |
| Total Assets | $3.25B | +1.8% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $147.3M | +168.8% | — |
| Capital Expenditures | $13.7M | +195.8% | — |
| Investing Cash Flow | -$44.8M | -3701.8% | — |
| Financing Cash Flow | -$221.7M | -82.0% | — |
| Free Cash Flow | $133.6M | +166.3% | — |
| +0.6% |
| Current Liabilities | $474.6M | +7.0% | +3.7% |
| Total Liabilities | $622.4M | +5.6% | -3.7% |
| Stockholders' Equity | $2.62B | +0.9% | +1.7% |